Sebaran Kanker di Indonesia, Riset Kesehatan Dasar 2007

(*) Corresponding Author
DOI : 10.33371/ijoc.v11i1.494


Cancer is one of the leading causes of death in the world. It takes an evidence-based strategy to address the increasing incidence of cancer in the world. To control the increase of cancer in Indonesia required control strategies of the key risk
factors associated with the incidence of cancer. Currently the data on the distribution of cancer in Indonesia is still limited. Key risk factors for cancer can be known from the existing types of cancer. By knowing the distribution of cancer
that is expected to become a factor in the prevention of cancer in Indonesia. The purpose of this paper is to describe the distribution of cancer in Indonesia by the community in 2007. The data used is data survey of basic health research
(Riskesdas) 2007. Design this study was a descriptive cross-sectional. The analysis showed that from 768 635 respondents there were 4647 (0.6%) respondents who had cancer. Central Java province was the province with the highest number of cancer patients (23.6%). Cervical and ovarian cancer as well as breast cancer were the most commonly found as many as 927 (20%) of respondents to cervical and ovarian cancer, and as many as 746 (16%) of respondents had breast cancer. Cervical and ovarian cancer were most commonly found in adults, with the status of
married, live in urban areas and have low education status. Breast cancer was most common in women aged adult, married status, living in urban, low educational status and low economic status.

Kanker merupakan salah satu penyebab kematian utama di dunia. Dibutuhkan strategi berbasis bukti untuk mengatasi meningkatnya kejadian kanker di dunia. Untuk mengontrol peningkatan kanker di Indonesia diperlukan strategi
pengendalian faktor risiko kunci yang berhubungan dengan kejadian kanker. Saat ini, data tentang sebaran kanker di Indonesia masih terbatas. Faktor risiko kunci kanker dapat diketahui dari jenis kanker yang ada. Dengan mengetahui
sebaran kanker yang ada diharapkan dapat menjadi salah satu acuan dalam penanggulangan kanker di Indonesia. Tujuan dari tulisan ini adalah untuk menggambarkan sebaran kanker di Indonesia berdasarkan komunitas pada tahun
2007. Data yang digunakan adalah data surveI Riset Kesehatan Dasar (Riskesdas) 2007. Desain studi ini adalah deskriptif cross-sectional. Hasil analisis menunjukkan bahwa dari 768.635 responden, 4.647 (0,6%) responden di antaranya menderita kanker. Jawa Tengah merupakan provinsi dengan jumlah penderita kanker tertinggi (23,6%). Kanker serviks uteri dan ovarium serta kanker payudara merupakan jenis kanker yang paling banyak ditemukan, yaitu 927 (20%) responden untuk kanker serviks uteri dan ovarium serta 746 (16%) responden kanker payudara. Kanker serviks uteri dan ovarium paling banyak ditemukan pada usia dewasa, dengan status menikah, hidup di perkotaan, dan memiliki status pendidikan rendah. Kanker payudara paling banyak ditemukan pada wanita usia dewasa, status menikah, tinggal di perkotaan, status pendidikan rendah, dan status ekonomi rendah.


distribution, cancer, Indonesia, cervical cancer, breast cancer, ovarian cancer, Riskesdas 2007


Word Health Organization. 2015. Cancer. (http://www.who.

int/mediacentre/factsheets/fs297/en/index.html), diakses 31

Oktober 2015)

Liu, Bo-Qi. et al. Emerging tobacco hazards in China: 1.Retrospective

proportional mortality study of one million deaths.1998.

( factsheets/fs297/en/index.html,

diakses 31 Oktober 2010)

Torre, Lindsey A. MSPH. Global cancer statistics. 2012. Volume 65,

Issue 2. March/April 2015. Pages 87–108. First published: 4

February 2015. DOI: 10.3322/caac.21262.,diunduh 6 oktober


Nur, F.D. 2003. Hubungan Pola Konsumsi Daging Merah, Aktivitas

Olahraga, dan Riwayat Keluarga dengan Terjadinya Penyakit Kanker

Kolon (Studi Kasus Kontrol di Rumah Sakit Kanker “Dharmais”

Jakarta Tahun 2003


diakses 28 Oktober 2010)

Word Health Organization. 2004. Cancer. (http://www.who.


full.pdf). diakses 10 Januari 2016.

Laporan hasil riset kesehatan dasar (RISKESDAS) nasional 2007.

Laporan penelitian, Badan Penelitian dan Pengembangan

Kementrian Kesehatan Republik Indonesia.

Human Papilloma Virus and Related Cancers Summary Report

Update. September 15, 2010. Indonesia (http://apps.

CFID=4436373&CFTOKEN, diakses 31 Oktober 2010)

Lowy, Douglas R and Schiller, John T. Reducing HPV-associated

Cancer Globally. 2013. (

articles/PMC3285475/, diakses 21 September 2016)

Word Health Organization. Human papillomavirus (HPV) and cervical

cancer. June 2016., diakses 20

September 2016).

Ferlay, Jacques International Journal of Cancer. Estimates

of worldwide burden of cancer in 2008: GLOBOCAN 2008.

First published: 17 June 2010.DOI: 10.1002/ijc.25516.(http://, diakses 21

September 2016).

Cutts, FT, et.all. Human papillomavirus and HPV vaccines: a review.

Bulletin of the World Health Organization Volume 85, Number 9,

September 2007, 719-726. (http://www.who.

int/bulletin/volumes/85/9/06-038414-table-T3.html, diakses 27

September 2016).

Lowy, Douglas R. and Schiller, John T. Prophylactic human

papillomavirus vaccines. First published May 1, 2006. J Clin

Invest. 2006;116(5):1167-1173. DOI:10.1172/JCI28607. (http://, diakses 6 Oktober 2016).

Forman D, de Martel C,Lacey CJ, et al. Global burden of

human papillomavirus and related diseases. Vaccine.

;30(suppl 5):F12 F23.(

pubmed/23199955, diakses 6 Oktober 2016).

Direktorat Pengendalian Penyakit Tidak Menular Direktorat

Jenderal Pengendalian Penyakit dan Penyehatan Lingkungan.

Deteksi Dini Kanker. 12 Desember 2013. (http://www.pptm., diakses 27

September 2016).

Laporan riset penyakit tidak menular tahun 2016. Balitbangkes

Kemenkes RI.

Direktorat Pengendalian Penyakit Tidak Menular Kementerian

Kesehatan Republik Indonesia. 2013. Buku Acuan Pencegahan

Kanker Payudara dan Kanker Leher Rahim. Panduan pencegahan

kanker leher rahim dan payudara untuk fasilitas dengan

sumber daya terbatas.

Steinbrook, Robert, M.D. 2006. Perspective The Potential of

Human Papillomavirus Vaccines. (

full/10.1056/NEJMp058305#t=article). Diakses 11 Januari 2016.

Baloch, Z. Prevalence of genital human papillomavirus

among rural and urban populations in southern Yunnan province,

China. 2016. Brazilian Journal of Medical and Biological Research

;49(6): e5254,

X20165254 ISSN 1414-431X


X20165254.pdf, diakses 7 Oktober 2016).

Word Health Organization. Summary of WHO Position Papers

- Recommendations for Routine Immunization. 21 Mei 2016.


table1.pdf?ua=1, diakses 26 September 2016).

Word Health Organization .WHO Cervical Cancer Prevention and

Control Costing (C4P) Tool User Guide. Versi 1.0. 2016.


GUIDE_V1.0.pdf, diakses 26 September 2016).

TC Jr, Wright and Kuhn L. Alternative approaches to cervical cancer

screening for developing countries. Best Pract Res Clin Obstet

Gynecol. 2012 Apr;26(2):197-208. doi:10.1016/



Word Health Organization. Cervical Cancer Screening in Developing

Countries Report of a WHO consultation. Published collaboratively

by Programme on Cancer Control, Department of Reproductive

Health and Research.


diakses 11 Oktober2016).

Sutoto, MD. “Dharmais” National Cancer Center Indonesia.

The role in National Cancer Control Programof Indonesia.

(”Dharmais” National

Cancer Center Indonesia. The role in National Cancer Control

Program of Indonesia) diakses 8 November 2016.

Article Statistic

Abstract view : 2776 times
PDF views : 5524 times

Dimensions Metrics

The PDF file you selected should load here if your Web browser has a PDF reader plug-in installed (for example, a recent version of Adobe Acrobat Reader).

If you would like more information about how to print, save, and work with PDFs, Highwire Press provides a helpful Frequently Asked Questions about PDFs.

Alternatively, you can download the PDF file directly to your computer, from where it can be opened using a PDF reader. To download the PDF, click the Download link above.

Fullscreen Fullscreen Off

Full Text: PDF

How To Cite This :


  • There are currently no refbacks.

Copyright (c) 2017 Indonesian Journal of Cancer

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.